TKNOAlpha Teknova, Inc.
5.470USD+6.94%Mkt Cap: 288.98M USDP/E: Last update: 2026-06-01

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary …

Indicators:|

Key Statistics

Company
Market Cap288.98M USD
Enterprise Value299.56M USD
Revenue (TTM)41.80M USD
Gross Profit13.44M USD
Net Income (TTM)-17.26M USD
Revenue/Share0.7810 USD
Last Price5.470 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees158
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-22.04
PEG
EV/EBITDA-31.63
EV/Revenue7.17
P/S6.93
P/B4.21
EPS (TTM)-0.31
EPS (Forward)-0.24
52W Range
1.91075% of range6.680
52W High6.680 USD
52W Low1.910 USD
Profitability
Gross Margin33.17%
Oper. Margin-38.80%
EBITDA Margin-22.66%
Profit Margin-42.59%
ROE-25.09%
ROA-16.66%
Growth
Revenue Growth13.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-8.65M USD
CapEx (TTM)1.15M USD
FCF Margin-5.71%
FCF Yield-0.83%
Net Debt10.04M USD
Net Debt/EBITDA-1.06
Balance Sheet
Debt/Equity0.41
Current Ratio4.59
Quick Ratio3.40
Book Value/Sh1.284 USD
Cash/Share0.3320 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)9.000 USD
Target Range7.000 USD12.00 USD
# Analysts3
Ownership
Shares Out.53.61M
Float10.88M
Insiders9.32%
Institutions84.72%
Short Interest
Short Ratio12.5d
Short % Float11.62%
Short % Out.2.37%
Shares Short1.27M
Short (prev mo.)1.33M
Technical
SMA 503.293 (+66.1%)
SMA 2003.922 (+39.5%)
Beta0.47
S&P 52W Chg27.70%
Avg Vol (30d)112.34K
Avg Vol (10d)159.06K
Technical Indicators
RSI (14)79.0
MACD0.3228
MACD Signal0.2316
MACD Hist.+0.0912
BB Upper4.648 USD
BB Middle3.882 USD
BB Lower3.117 USD
BB Width39.45%
ATR (14)0.3578 USD
Vol Ratio (20d)0.96x